Brain cell injection trial offers new hope for advanced Parkinson's patients
NCT ID NCT07550374
First seen May 02, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This early-stage study tests a single injection of special nerve cells (NouvNeu001) in 10 people with moderate-to-advanced Parkinson's who have already had deep brain stimulation or similar brain surgery. The main goal is to check if the injection is safe and tolerable. Researchers will also watch for any improvement in movement and daily function over nearly two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of USTC
Hefei, Anhui, 230001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.